Kevin R. Sayer - Jan 18, 2022 Form 4 Insider Report for DEXCOM INC (DXCM)

Signature
By: Jereme Sylvain For: Kevin R Sayer
Stock symbol
DXCM
Transactions as of
Jan 18, 2022
Transactions value $
-$9,875,800
Form type
4
Date filed
1/20/2022, 04:35 PM
Previous filing
Dec 17, 2021
Next filing
Feb 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Sale -$1.32M -3K -3.67% $438.81 78.7K Jan 18, 2022 Direct F1, F2
transaction DXCM Common Stock Award $0 +38.6K +49.03% $0.00 117K Jan 18, 2022 Direct F2, F3
transaction DXCM Common Stock Sale -$8.56M -19.7K -16.77% $435.06 97.6K Jan 18, 2022 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 31, 2020, Mr. Sayer adopted a 10b5-1 Plan, which was amended effective June 15, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2 Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022.
F3 Represents performance stock units ("PSUs") granted to the reporting person on March 8, 2019 that vested on January 18, 2022, with the applicable performance achieved.
F4 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.